Statins associated diabetes: state of the problem in 2018
Statin therapy is highly effective and obligatory method of cardiovascular risk reduction in primary and secondary prevention. It is well tolerated by patients. However the risk of new diabetes cases onset, associated with statins, remains discussed actively. The review is focused on recent data on...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2018-09-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2962 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850030786903801856 |
|---|---|
| author | Zh. D. Kobalava P. V. Lazarev S. V. Villevalde |
| author_facet | Zh. D. Kobalava P. V. Lazarev S. V. Villevalde |
| author_sort | Zh. D. Kobalava |
| collection | DOAJ |
| description | Statin therapy is highly effective and obligatory method of cardiovascular risk reduction in primary and secondary prevention. It is well tolerated by patients. However the risk of new diabetes cases onset, associated with statins, remains discussed actively. The review is focused on recent data on the prevalence of this adverse event, risk/benefit ratio, possible mechanisms and patients populations with the highest risk of development of statin related diabetes. Practitioners tactics analyzed in diabetes development when taking statins. The article goes with recent international guidelines data, as the consensus letters; also, a comparison provided with novel medications used in cardiovascular prevention. |
| format | Article |
| id | doaj-art-685f665b095b4d6abb9d05ec7e335053 |
| institution | DOAJ |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2018-09-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-685f665b095b4d6abb9d05ec7e3350532025-08-20T02:59:07Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202018-09-0109899910.15829/1560-4071-2018-9-89-992481Statins associated diabetes: state of the problem in 2018Zh. D. Kobalava0P. V. Lazarev1S. V. Villevalde2Peoples’ Friendship University of RussiaPeoples’ Friendship University of RussiaAlmazov National Research Medical Center of the Ministry of HealthStatin therapy is highly effective and obligatory method of cardiovascular risk reduction in primary and secondary prevention. It is well tolerated by patients. However the risk of new diabetes cases onset, associated with statins, remains discussed actively. The review is focused on recent data on the prevalence of this adverse event, risk/benefit ratio, possible mechanisms and patients populations with the highest risk of development of statin related diabetes. Practitioners tactics analyzed in diabetes development when taking statins. The article goes with recent international guidelines data, as the consensus letters; also, a comparison provided with novel medications used in cardiovascular prevention.https://russjcardiol.elpub.ru/jour/article/view/2962statinsdiabetescardiovascular risk |
| spellingShingle | Zh. D. Kobalava P. V. Lazarev S. V. Villevalde Statins associated diabetes: state of the problem in 2018 Российский кардиологический журнал statins diabetes cardiovascular risk |
| title | Statins associated diabetes: state of the problem in 2018 |
| title_full | Statins associated diabetes: state of the problem in 2018 |
| title_fullStr | Statins associated diabetes: state of the problem in 2018 |
| title_full_unstemmed | Statins associated diabetes: state of the problem in 2018 |
| title_short | Statins associated diabetes: state of the problem in 2018 |
| title_sort | statins associated diabetes state of the problem in 2018 |
| topic | statins diabetes cardiovascular risk |
| url | https://russjcardiol.elpub.ru/jour/article/view/2962 |
| work_keys_str_mv | AT zhdkobalava statinsassociateddiabetesstateoftheproblemin2018 AT pvlazarev statinsassociateddiabetesstateoftheproblemin2018 AT svvillevalde statinsassociateddiabetesstateoftheproblemin2018 |